Dr Ing Financials
| DRPRF Stock | USD 51.30 1.30 2.60% |
DRPRF |
Understanding current and past Dr Ing Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Dr Ing's financial statements are interrelated, with each one affecting the others. For example, an increase in Dr Ing's assets may result in an increase in income on the income statement.
Dr Ing Stock Summary
Dr Ing competes with Dr Ing, Honda, DENSO, Denso Corp, and Volkswagen. Porsche AG engages in automotive and financial services businesses. Porsche AG operates as a subsidiary of Porsche Holding Stuttgart GmbH. Dr ING is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | Porscheplatz 1, Stuttgart, |
| Sector | Consumer Cyclical |
| Industry | Auto Manufacturers |
| Benchmark | Dow Jones Industrial |
| Website | www.porsche.com/international |
| Phone | 49 711 911 0 |
| Currency | USD - US Dollar |
DRPRF Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Dr Ing's current stock value. Our valuation model uses many indicators to compare Dr Ing value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dr Ing competition to find correlations between indicators driving Dr Ing's intrinsic value. More Info.Dr Ing hc is rated # 2 in profit margin category among its peers. It also is rated # 2 in operating margin category among its peers reporting about 1.45 of Operating Margin per Profit Margin. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dr Ing's earnings, one of the primary drivers of an investment's value.Dr Ing hc Systematic Risk
Dr Ing's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Dr Ing volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Dr Ing hc correlated with the market. If Beta is less than 0 Dr Ing generally moves in the opposite direction as compared to the market. If Dr Ing Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Dr Ing hc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Dr Ing is generally in the same direction as the market. If Beta > 1 Dr Ing moves generally in the same direction as, but more than the movement of the benchmark.
Dr Ing October 25, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Dr Ing help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Dr Ing hc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Dr Ing hc based on widely used predictive technical indicators. In general, we focus on analyzing DRPRF Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Dr Ing's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.89 | |||
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 13.17 | |||
| Value At Risk | (5.31) | |||
| Potential Upside | 4.38 |
Complementary Tools for DRPRF Pink Sheet analysis
When running Dr Ing's price analysis, check to measure Dr Ing's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Ing is operating at the current time. Most of Dr Ing's value examination focuses on studying past and present price action to predict the probability of Dr Ing's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Ing's price. Additionally, you may evaluate how the addition of Dr Ing to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |